K-P releases Rs440m to settle IHP salaries
On the directives of Khyber-Pakhtunkhwa Health Advisor Ehtesham Ali, Rs440 million has been released to clear three months' pending salaries of over 4,500 employees of the Integrated Health Program (IHP).
In his statement, the Health Advisor assured that all employees would receive their salaries before Ramazan.
He instructed the relevant authorities to ensure timely transfers of payments to employees' accounts without delay.
Emphasizing the need for reforms to streamline project operations, he stated that no employee's salary would be withheld.
"There is no place in my team for those who cannot deliver," he asserted. Expressing concern over frequent salary delays and protests for project extensions, Ehtesham Ali directed officials to begin preparations for the upcoming budget immediately.
He urged consultations with stakeholders to ensure efficient financial planning and prevent such disruptions in the future.
The advisor further stated that the next Annual Development Program (ADP) would include only those schemes that enhance service delivery and benefit the public, rather than launching unnecessary new projects.
Background
In December 2024, The Express Tribune reported that IHP, jointly managed by the Lady Health Workers (LHWs) program and the nutrition initiative, faces severe financial constraints, hindering its effectiveness.
Official sources said that both programs have fallen short of their targets due to insufficient funding.
Approximately 4,000 IHP employees have gone without salaries for the past five months, receiving payment only once during this period, according to a health department official.
Introduced in 2014 across all four provinces, the IHP underwent challenges after the 18th amendment, requiring individual provinces to create their PC-1 plans.
The previous government's Rs7.5 billion PC-1, developed by consultants from Punjab without a baseline survey, displayed numerous shortcomings, including the delayed recruitment of Lady Health Workers and trained community midwives over four years.
Despite completing their two-year training, these midwives remain unutilized, incurring significant costs to the health department, supported by international donor organizations. Additionally, LHWs and CMWs lack access to government-provided medicines.
The IHP's primary goal is to reduce maternal deaths during childbirth from 165 per 1,000 to 40. Stabilization centers face similar challenges, with no available food supplements despite the declared nutrition emergency in the province. Only Unicef is currently providing food supplements to select districts, while the government struggles to recruit nutrition specialists and purchase food supplements due to financial constraints.
Targets for underweight childbirths have been substantially missed, raising concerns about the project's overall efficacy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Express Tribune
29-06-2025
- Express Tribune
'The Wild West' of weight loss
In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer. Each week the mother of two injects herself with weight-loss drugs, two of which are in clinical trials and not yet approved for sale by the US Food and Drug Administration. One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound. Spencer, 50, is not part of any drug trial but mixes the cocktails herself, using tiny doses that she believes are safe. The total cost is about $50 monthly, as little as one-tenth of what she would expect to pay their makers for full treatment. The drugs – glucagon-like peptide-1 (GLP-1) weight-loss medicines – are manufactured and shipped from China, according to the packaging. She orders them through online vendors. Spencer belongs to a fast-growing group of Americans turning to what many call the "grey market" for obesity medicines, bringing cheap active ingredients from China often labelled as for research purposes, according to import data and social media postings. It's a trend that drugmakers Lilly and Novo Nordisk, which makes Wegovy, say is dangerous as well as illicit. Reuters tracked online forums and interviewed seven people who said they bought obesity medicines through this market, including an attorney in Arizona who works for a state insurance agency, a retired nurse in Illinois and a Type 1 diabetic in Louisiana, who said the medicine helped cut her insulin intake by more than half. For more than a year there has been demand for cheap Chinese-made powders, exacerbated by limited health insurance coverage in the US Buyers told Reuters the grey market received a boost from an FDA ruling last year that US compounding pharmacies – outsourcing facilities that create drugs in shortage – must stop selling obesity medicines more cheaply than the companies that developed them. Risky business Shipments of such active ingredients from Chinese entities not registered with the FDA jumped by 44 per cent in January from the previous month, according to research by the Partnership for Safe Medicines, a public health group focused on the safety of prescription drugs. It said its findings are likely an undercount, because unregistered vendors may not disclose that their parcels contain medicines. Packages valued at less than $800 that enter the US under the de minimis rule are not included in the data. Nearly three-quarters of US adults are overweight or obese, according to government estimates, but a survey by nonprofit health policy research organisation KFF found only about 8 per cent say they have taken medicine for weight loss. Most of the grey market buyers Reuters interviewed had told their medical providers they were taking GLP-1 medicines but not where or how they bought them. Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer. Many Americans have paid out of pocket for cheaper compounded drugs. Interest in taking small doses of the drugs has also spurred the online marketplace, buyers said. Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research materials to sidestep regulatory scrutiny. They swap advice for navigating the market, exchanging information on vendors, shipping and dosage, and sometimes clubbing together to cover the cost of testing the powders. One forum is called StairwayToGray. It has more than 21,000 members on Telegram and recently was gaining nearly 1,000 members weekly. It did not respond to Reuters' inquiries, and blocked access to the forum after receiving them. It has a website where it says it does not facilitate group purchases. "This community is filling the gaps and being our own regulators, ensuring testing and access for everyone who needs it. Because you shouldn't have to choose between your health or your wallet," it says. Spencer stores her stocks in her fridge and makes them up in the kitchen – carefully measuring sterile water, rolling the vial between her fingers until the powder dissolves, and drawing the liquid into a syringe before injecting it into her thigh or belly. She has lost 24 pounds. "This is working so well for me. It's so easy. It's cheap," said Spencer, who assumes her health plan wouldn't cover the drugs. "I don't know what I would do without this medicine." 'Very dangerous' In February, 38 US state and territory attorney generals wrote the FDA seeking action against illegally sold weight-loss medicines, including "research purposes only" ingredients from China. "Much like with counterfeit versions, these active ingredients come from unregulated, undisclosed sources ... and pose risks of contamination and inclusion of foreign substances," they said. Shabbir Safdar, executive director of the Partnership for Safe Medicines, said unapproved drugs can have problems with sterility, purity and consistency. "It can be very dangerous. You're playing the role of your own doctor, pharmacist, and FDA inspector," he said. Of those interviewed, only Spencer reported any problems: She once got her math wrong and overdosed, resulting in several days of severe flu-like symptoms. Lilly said it had taken many steps to address patient safety risks posed by the proliferation of unsafe or untested tirzepatide. The company said it is filing lawsuits, educating consumers and working with social media companies to identify and remove posts that promote unsafe products, including those described as "research use only." "We will continue to take action to stop those who threaten patient safety and urgently call on regulators and law enforcement to do the same," a Lilly spokesperson told Reuters. Novo Nordisk also said it continues to take action against entities that violate laws and regulations and put patient safety at risk. America's Poison Control agency, which maintains the nation's poison data surveillance system and monitors GLP-1 exposures, said it could not reliably track cases involving unregulated "research chemical powders" because they are sold under various names and formulations. Reuters
Business Recorder
25-06-2025
- Business Recorder
Punjab budget reflects deliberate realignment of fiscal priorities?
LAHORE: The structure of the Punjab budget for FY 2025–26 reflects a deliberate and disciplined realignment of fiscal priorities. While curtailing non-essential current expenditure, the government has expanded development spending through the largest-ever Annual Development Programme (ADP) in Punjab's history, with 47.3% increase over previous year's ADP. This expansion has been made possible through robust public financial management reforms, including but not limited to the successful retirement of unsustainable commodity operations debt. As per budget document, this year's budget reflects a strategic shift from foundational infrastructure to transformative development. While the first year focused on road connectivity and basic service delivery, FY 2025–26 marks the next logical step i.e., empowering communities through integrated urban development and rural uplift. Transport has emerged as a key priority with a focus on expanding eco-friendly public mobility options, including the introduction of electric buses to reduce urban congestion and environmental impact. The Punjab government has also placed unprecedented emphasis on education—expanding access through scholarships, laptops, school meals, and higher education grants. Health remains a cornerstone, with flagship health initiatives such as Medical City, free medicine, and new centres for cancer and cardiac care. New frontiers in IT, affordable Housing and Climate Action signal the province's ambition to build an inclusive, forward-looking economy, the budget document reveals. On the other hand, the Punjab government, in view of its rapidly increasing annual pension expense and burgeoning accrued pension liabilities accorded approval of the Defined Contribution Pension Scheme. Under the scheme, employees would be contributing for its pension contrary to the defined benefit scheme where government finances solely to the pension. This would significantly reduce the piling of accrued liability, and this has been enacted for the employees joining the government service on or after January 08, 2024. Moreover, the Punjab government has implemented the deregulation of commodity operations of wheat which previously was financed through commercial borrowing from the financial institutions. The scheme had accumulated a circular debt of Rs 629 billion outstanding at June 2022 due to unfunded general subsidy expenditure. The government has eliminated this debt from provincial revenues leading to reduction of commodity debt outstanding down to Rs 13.9 billion at April`25, which is fully backed by the wheat stock leveraging the saving of future debt service in the range of approximately Rs 50 billion per annum. Copyright Business Recorder, 2025
Express Tribune
19-06-2025
- Express Tribune
Punjab takes over long-stalled hospital project
Following years of federal inaction, the Punjab government is set to revive the long-abandoned Rawalpindi Mother and Child Hospital project under its Annual Development Programme (ADP). The revised plan envisions the completion of the facility as a state-of-the-art Children's Hospital, with the project's cost now escalated to Rs9 billion. PHOTO: EXPRESS The long-delayed Rawalpindi Mother and Child Hospital project — under construction for the past 22 years and with its cost rising from Rs1.5 billion to Rs9b billion — has now been transferred from the federal to the Punjab government, which will construct a Children's Hospital instead. The status of the project has been revised, and it has been decided to complete the unfinished building and establish a Children's Hospital instead. The Punjab government has issued a notification to include the project in its Annual Development Programme (ADP) and to prepare a new PC-1 for its execution. The foundation stone of the hospital was laid by two former Prime Ministers, Shaukat Aziz and Imran Khan. In addition, the former Chief Justice of the Supreme Court, Justice Saqib Nisar visited the site just 23 days before the 2018 general elections and announced that the project would be completed under the supervision of a special cell of the Supreme Court. According to the notification issued on June 16 by the Secretary, Specialised Healthcare and Medical Education Department, Punjab, Dr Hina Sattar, Head of Paediatrics at Rawalpindi Medical University, has been appointed as Project Director for the establishment of the Children's Hospital under the ADP. She will coordinate with Assistant Professor Dr Masood Sadiq, the Vice Chancellor of the University of Child Health Sciences, Lahore, to prepare a revised PC-1 for the project. It is worth noting that former federal Interior Minister Sheikh Rashid Ahmed had facilitated the foundation-laying of a 200-bed Mother and Child Hospital by then Prime Minister Shaukat Aziz during the federal government formed after the 2002 elections. At the time, the total estimated cost of the project was Rs1.5b. However, the project remained incomplete during the five-year tenure of that government. While the main structure was constructed, critical work, including finishing, renovation, machinery installation, and recruitment of human resources, was never completed. From 2008 to 2017, the project remained abandoned. Then, on July 1, 2018 — just 23 days before the general elections — then Chief Justice Saqib Nisar, along with Sheikh Rashid Ahmed, visited the site and announced that the SC's special cell would now oversee the project's completion. Later, after the PTI came to power following the 2018 elections, then Prime Minister Imran Khan visited the site once again and reiterated the promise to complete the hospital. Despite significant progress during PTI's three-and-a-half-year tenure, the project still could not be completed. The construction eventually halted, and the partially built structure began to deteriorate due to weather and neglect. Now, the project — previously under federal jurisdiction — has officially been handed over to the Punjab government, which will provide the funding and complete the project as a Children's Hospital under a new PC-1.
